You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
吉宏股份(002803.SZ):長榮健康獲醫療器械註冊證和醫療器械生產許可證 擬投建口罩生產線20條
格隆匯 03-18 18:27

格隆匯3月18日丨吉宏股份(002803.SZ)公佈,公司全資子公司江西吉宏供應鏈管理有限公司(“江西吉宏)2020227日與天津長榮科技集團股份有限公司(長榮股份)簽署《增資入股協議書》,以自有資金人民幣667萬元對長榮股份全資子公司天津長榮健康科技有限公司(“長榮健康)進行增資,增資完成後,江西吉宏持股比例40%,長榮股份持股比例60%

公司於2020317日收到長榮健康通知,長榮健康已取得由天津市藥品監督管理局核准頒發的《醫療器械註冊證》和《醫療器械生產許可證》。

醫療器械註冊證:產品名稱為一次性使用醫用口罩;型號、規格:耳掛式(非無菌性),規格:175mm*95mm

產品為疫情應急審批產品,註冊證有效期為一年。企業在延續註冊時,應當按照《醫療器械註冊管理辦法》的要求完善所有註冊申報資料。

由於疫情原因,目前國內企業復工復產存在大量基本防護物資如口罩需求,同時隨着疫情在國外的持續發酵,口罩需求仍將持續加大。長榮健康取得《醫器械註冊證》和《醫療器械生產許可證》後,將全力部署口罩生產安排,積極保障口罩產能及訂單要求。根據生產規劃,長榮健康擬投入建設口罩生產線20條,目前已建成6條,預計本月底建成12條生產線、日產能約72萬隻/天,剩餘8條生產線預計4月完成,全部投產後整體產能約120萬隻/天。

藉助公司與長榮股份兩家上市公司的資源渠道,長榮健康口罩線上線下同步開展銷售,並全力部署生產、持續增加口罩市場供應,為疫情防控貢獻力量。同時長榮健康將根據海外疫情防控需求,積極申請醫療器械出口資質認證(含FDACE等),開拓海外市場。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account